Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

Novaplex SARS-CoV-2 Variant assay mutations coverage table includes mutations consistent with Omicron, Stealth Omicron, Alpha, Beta, Gamma and Delta variants

The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron and its Stealth version. Published on: PR Newswire Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant landscape. The Novaplex™ SARS-CoV-2 Variants VII assay addresses Omicron and […]

Omicron Variant: Letter to our customers

To Our Valued Seegene Customer, The World Health Organization has identified the Omicron variant (B.1.1.529) as the latest strain of the SARS-CoV-2 virus to be designated as a Variant of Concern. As the first cases are emerging in the US, Seegene confirms that the performance or quality of the Seegene EUA Allplex™ 2019-nCoV Assay is […]

The Omicron Variant: What We Know So Far

Image with the word 'Omicron' and cartoon images of viruses depicting Omicron variant

On Friday, November 26, the Omicron variant of SARS-CoV-2, the agent behind COVID-19 was classified as a variant of concern by the World Health Organization (WHO) after reports of its detection and genetic sequence were released from South Africa. A variant of concern is a viral variant that is considered more contagious, more virulent, or better […]

Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant

Published on: PR Newswire The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube Seegene will support countries in need of diagnostics to help slow Omicron’s spread Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is […]

The SARS CoV-2 Lambda Variant: Here’s What You Should Know

Like all RNA viruses, SARS-CoV-2 is prone to mutations—adaptive changes that can alter a virus’ pathogenic potential and other characteristics. These mutations can create distinct variants of the virus, adding complexity to what has already become the most significant global public health challenge since the 1918 influenza pandemic.    On June 15, 2021, the World Health […]

The Rapid Evolution of Seegene’s COVID-19 Solutions

It’s been one year since Seegene produced a complete respiratory diagnostic test that has taken the uncertainty out of differentiating COVID-19 infection from other respiratory illnesses Fast Response In January 2020, before a single patient with SARS-CoV-2 virus had been identified in South Korea, molecular diagnostic company Seegene leveraged its proven automated assay development platform […]

The Future of Diagnostics: Syndromic Assays

How High Multiplex assays that test for many common pathogens at once can accelerate diagnostics and facilitate a higher quality of care When a patient presents with a symptom, many pathogens could be at fault. Standard clinical practice is to take a sample from the patient and perform a diagnostic test or tests for suspected […]